30 varieties of traditional Chinese medicine injection stopped production

It was learned from the Symposium on risk control of traditional Chinese medicine injection held by China Pharmaceutical News Agency on May 24 that after strict control and active guidance of traditional Chinese medicine injection policy, the situation that there are many kinds of traditional Chinese medicine injection and the safety cannot be evaluated has been basically reversed At present, China has 141 traditional Chinese medicine injections and 154 enterprises in production, of which 30 varieties are not produced by enterprises The symposium mainly discussed the core links of risk control of traditional Chinese medicine injection, the progress and requirements of national safety re evaluation of traditional Chinese medicine injection, and the development direction of traditional Chinese medicine injection industry in the new era Experts and enterprise representatives at the meeting agreed that the current unsafe factors of traditional Chinese medicine injection mainly include: unstable raw materials of traditional Chinese medicine, simple and rough current production process, imperfect current quality standards, lack of rationality of clinical compatibility, increased adverse reactions caused by blind compatibility, particle changes of traditional Chinese medicine injection, individual differences of patients on drugs Produce different reactions, etc Zhang Boli, President of the Chinese Academy of traditional Chinese medicine and academician of the Chinese Academy of engineering, said that the initiative of enterprises to stop production of some products is conducive to risk control Traditional Chinese medicine injection is a breakthrough innovation in the formulation of traditional Chinese medicine for thousands of years, which is recognized as one of the development directions of modern traditional Chinese medicine in the industry However, it is only a few decades since its research and development, so it should have a dialectical, historical and scientific perspective The relevant departments of drug R & D, production, use and supervision shall make full cooperation to formulate reasonable, perfect and progressive industrial policies, so as to gradually eliminate the backward varieties of traditional Chinese medicine injection, improve the market access standards, encourage the use of high-tech means to eliminate potential safety hazards, realize the modernization of traditional Chinese medicine, and enhance the international competitiveness of traditional Chinese medicine.